{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:23:20Z","timestamp":1783347800622,"version":"3.54.6"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiometabolic conditions\u2014including cardiovascular disease, type 2 diabetes, and obesity\u2014are highly prevalent among individuals with psychotic disorders. These conditions contribute substantially to reduced life expectancy, diminished quality of life, and increased societal and economic burdens. Thus, effective, individualized interventions are urgently needed. Outpatient psychiatric clinics offer an ideal setting for such efforts owing to regular patient contact and access to multidisciplinary care. We have developed a comprehensive, clinically integrated trial aimed at improving cardiometabolic health, promoting healthier lifestyles, and enhancing quality of life for individuals with psychotic disorders receiving care in the Greater Gothenburg region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LAGOM is a multicenter, naturalistic, quasi-experimental case\u2012control trial conducted across six geographically separate outpatient psychosis clinics within the Department of Psychotic Disorders at Sahlgrenska University Hospital, a multi-site university hospital in the Greater Gothenburg region. A total of 650 adults with psychotic disorders will be recruited from these clinics. Two clinics will implement the LAGOM intervention, whereas four will serve as control sites delivering usual care. The intervention is embedded within routine psychiatric care and grounded in behavioral science. It includes comprehensive cardiometabolic risk assessments, two visual motivational tools (QRISK3 and a body composition analyzer), personalized follow-up plans, risk-oriented referrals to primary care, and structured education for patients, relatives, and staff. The intervention is designed to be scalable, sustainable, and tailored to individual patient needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>If proven superior to usual care, this pragmatic, multicomponent intervention\u2014delivered within routine psychiatric care\u2014could improve cardiometabolic health and quality of life for individuals with psychotic disorders. Embedding the intervention within existing clinical structures enhances its scalability and feasibility and, if effective, could serve as a model for wider implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov (NCT06781801; date registered: 16 January 2025).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial status<\/jats:title>\n                    <jats:p>Recruitment started on 27 February 2025 and will be completed on 31 December 2026. The current clinical investigation plan version is 3.1, dated 21 October 2025.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08315-3","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:38:40Z","timestamp":1782229120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multicenter, cluster-based, superiority trial of a multicomponent lifestyle intervention versus usual care for reducing cardiometabolic risk in individuals with psychotic disorders over 36 months: the LAGOM protocol"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7043-1135","authenticated-orcid":false,"given":"Hemen","family":"Najar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Jedenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fr\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Holmbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin K\u00f6lborg","family":"Bj\u00f6rlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Saari-Bladmyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Hantelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"W\u00e5linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joacim","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Klysing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Rundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"K\u00f6rvek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Rydell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Heder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zangin","family":"Zeebari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"6","key":"8315_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/MLR.0b013e31820bf86e","volume":"49","author":"BG Druss","year":"2011","unstructured":"Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011;49(6):599\u2013604.","journal-title":"Med Care"},{"issue":"1","key":"8315_CR2","doi-asserted-by":"publisher","first-page":"e55176","DOI":"10.1371\/journal.pone.0055176","volume":"8","author":"M Nordentoft","year":"2013","unstructured":"Nordentoft M, Wahlbeck K, H\u00e4llgren J, Westman J, Osby U, Alinaghizadeh H, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS ONE. 2013;8(1):e55176.","journal-title":"PLoS ONE"},{"issue":"4","key":"8315_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/appi.ps.54.4.565","volume":"54","author":"DB Allison","year":"2003","unstructured":"Allison DB, Mackell JA, McDonnell DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv. 2003;54(4):565\u20137.","journal-title":"Psychiatr Serv"},{"key":"8315_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/NDT.S282856","volume":"17","author":"B Kearns","year":"2021","unstructured":"Kearns B, Cooper K, Cantrell A, Thomas C. Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain. Neuropsychiatr Dis Treat. 2021;17:125\u201337.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"8315_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","volume":"18","author":"RE Nielsen","year":"2021","unstructured":"Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2021;18(2):136\u201345.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"8315_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","volume":"10","author":"MDEH Correll","year":"2011","unstructured":"Correll MDEH, Bobes CU, Cetkovich-Bakmas J, Cohen M, Asai D. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52\u201377.","journal-title":"World Psychiatry"},{"issue":"9426","key":"8315_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","volume":"363","author":"KT Mueser","year":"2004","unstructured":"Mueser KT, McGurk SR, Schizophrenia. Lancet. 2004;363(9426):2063\u201372.","journal-title":"Lancet"},{"key":"8315_CR8","unstructured":"Nationella riktlinjer f\u00f6r prevention och behandling vid oh\u00e4lsosamma levnadsvanor \u2013 St\u00f6d f\u00f6r styrning och ledning (Published on January 1st 2018): The Swedish National Board of Health and Welfare. 2018 [https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/nationella-riktlinjer\/2018-6-24.pdf]"},{"issue":"2","key":"8315_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/j.2051-5545.2011.tb00036.x","volume":"10","author":"M De Hert","year":"2011","unstructured":"De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10(2):138\u201351.","journal-title":"World Psychiatry"},{"issue":"1","key":"8315_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12888-023-05022-1","volume":"23","author":"D Quadackers","year":"2023","unstructured":"Quadackers D, Liemburg E, Bos F, Doornbos B, Risselada A, Berger M, et al. Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients. BMC Psychiatry. 2023;23(1):536.","journal-title":"BMC Psychiatry"},{"key":"8315_CR11","unstructured":"Nationell utv\u00e4rdering av v\u00e5rd och st\u00f6d vid schizofreni och schizofreniliknande tillst\u00e5nd (Published on October. 3rd, 2022): The Swedish National Board of Health and Welfare; 2022 [https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/nationella-riktlinjer\/2022-8-8072.pdf]"},{"issue":"17","key":"8315_CR12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJMoa1214530","volume":"368","author":"GL Daumit","year":"2013","unstructured":"Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368(17):1594\u2013602.","journal-title":"N Engl J Med"},{"issue":"5","key":"8315_CR13","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1097\/MJT.0000000000000708","volume":"27","author":"HJ S\u00f8gaard","year":"2020","unstructured":"S\u00f8gaard HJ, H\u00f8jlund M, Elliott A, Viuff AG, Vandborg K, Viuff J, et al. Effect of a 30-Month Health-Promoting Program on the Prevalence of Cardiovascular Risk Factors in Patients With First Episode Schizophrenia. Am J Ther. 2020;27(5):e439\u201349.","journal-title":"Am J Ther"},{"issue":"1","key":"8315_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/PRA.0000000000000278","volume":"24","author":"P Hjorth","year":"2018","unstructured":"Hjorth P, Espensen CH, Madsen NJ, Viuff AG, Munk-J\u00f8rgensen P. Reducing the Risk of Type 2 Diabetes in Nonselected Outpatients With Schizophrenia: A 30-Month Program. J Psychiatr Pract. 2018;24(1):21\u201331.","journal-title":"J Psychiatr Pract"},{"issue":"8","key":"8315_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.eurpsy.2015.09.006","volume":"30","author":"R Masa-Font","year":"2015","unstructured":"Masa-Font R, Fern\u00e1ndez-San-Mart\u00edn MI, Mart\u00edn L\u00f3pez LM, Alba Mu\u00f1oz AM, Oller Canet S, Mart\u00edn Royo J, et al. The effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness after 3-month follow-up: CAPiCOR randomized clinical trial. Eur Psychiatry. 2015;30(8):1028\u201336.","journal-title":"Eur Psychiatry"},{"key":"8315_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1471-244X-13-263","volume":"13","author":"F Gaughran","year":"2013","unstructured":"Gaughran F, Stahl D, Ismail K, Atakan Z, Lally J, Gardner-Sood P, et al. Improving physical health and reducing substance use in psychosis\u2013randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial. BMC Psychiatry. 2013;13:263.","journal-title":"BMC Psychiatry"},{"key":"8315_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.schres.2019.03.026","volume":"208","author":"J Westman","year":"2019","unstructured":"Westman J, Eberhard J, Gaughran FP, Lundin L, Stenmark R, Edman G, et al. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT). Schizophr Res. 2019;208:138\u201344.","journal-title":"Schizophr Res"},{"key":"8315_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2018.06.058","volume":"202","author":"G Ashdown-Franks","year":"2018","unstructured":"Ashdown-Franks G, Williams J, Vancampfort D, Firth J, Schuch F, Hubbard K, et al. Is it possible for people with severe mental illness to sit less and move more? A systematic review of interventions to increase physical activity or reduce sedentary behaviour. Schizophr Res. 2018;202:3\u201316.","journal-title":"Schizophr Res"},{"key":"8315_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12888-015-0465-2","volume":"15","author":"H Speyer","year":"2015","unstructured":"Speyer H, N\u00f8rgaard HC, Hjorth\u00f8j C, Madsen TA, Drivsholm S, Pisinger C, et al. Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity. BMC Psychiatry. 2015;15:119.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"8315_CR20","first-page":"20","volume":"44","author":"L Guti\u00e9rrez-Rojas","year":"2016","unstructured":"Guti\u00e9rrez-Rojas L, Pulido S, Azanza JR, Bernardo M, Rojo L, Mesa FJ, et al. Risk factor assessment and counselling for 12 months reduces metabolic and cardiovascular risk in overweight or obese patients with schizophrenia spectrum disorders: The CRESSOB study. Actas Esp Psiquiatr. 2016;44(1):20\u20139.","journal-title":"Actas Esp Psiquiatr"},{"key":"8315_CR21","doi-asserted-by":"publisher","first-page":"e081660","DOI":"10.1136\/bmj-2024-081660","volume":"389","author":"A Hr\u00f3bjartsson","year":"2025","unstructured":"Hr\u00f3bjartsson A, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081660.","journal-title":"BMJ"},{"issue":"25","key":"8315_CR22","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 risk prediction","year":"2021","unstructured":"SCORE2 risk prediction. algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354.","journal-title":"Eur Heart J"},{"issue":"1","key":"8315_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"10","key":"8315_CR24","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"16","key":"8315_CR25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789\u201395.","journal-title":"Arch Intern Med"},{"key":"8315_CR26","volume-title":"Indikatorer f\u00f6r bra matvanor. Resultat fr\u00e5n intervjuunders\u00f6kningar 2008","author":"W Becker","year":"2009","unstructured":"Becker W. Indikatorer f\u00f6r bra matvanor. Resultat fr\u00e5n intervjuunders\u00f6kningar 2008. Uppsala: Livsmedelsverket; 2009."},{"key":"8315_CR27","unstructured":"Population statistics on 31st December. 2024 https:\/\/www.scb.se\/en\/finding-statistics\/statistics-by-subject-area\/population-and-living-conditions\/population-composition-and-development\/population-statistics\/pong\/tables-and-graphs\/population-statistics---year\/population-in-the-country-counties-and-municipalities-on-31-december-2024-and-population-change-in-2024\/: Statistics Sweden; 2024 [updated February 21st, 2025."},{"key":"8315_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1745017901208010144","volume":"8","author":"T Nord\u00e9n","year":"2012","unstructured":"Nord\u00e9n T, Malm U, Norlander T. Resource Group Assertive Community Treatment (RACT) as a Tool of Empowerment for Clients with Severe Mental Illness: A Meta-Analysis. Clin Pract Epidemiol Ment Health. 2012;8:144\u201351.","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"1","key":"8315_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pchj.1","volume":"1","author":"T Nord\u00e9n","year":"2012","unstructured":"Nord\u00e9n T, Eriksson A, Kjellgren A, Norlander T. Involving clients and their relatives and friends in psychiatric care: Case managers\u2019 experiences of training in resource group assertive community treatment. Psych J. 2012;1(1):15\u201327.","journal-title":"Psych J"},{"issue":"Suppl 3","key":"8315_CR30","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1016\/S0924-9338(05)80182-8","volume":"20","author":"J Bobes","year":"2005","unstructured":"Bobes J, Garc\u00eda-Portilla P, S\u00e1iz PA, Bascar\u00e1n T, Bouso\u00f1o M. Quality of life measures in schizophrenia. Eur Psychiatry. 2005;20(Suppl 3):S313\u20137.","journal-title":"Eur Psychiatry"},{"issue":"9","key":"8315_CR31","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/oby.2009.87","volume":"17","author":"C Mason","year":"2009","unstructured":"Mason C, Katzmarzyk PT. Variability in waist circumference measurements according to anatomic measurement site. Obes (Silver Spring). 2009;17(9):1789\u201395.","journal-title":"Obes (Silver Spring)"},{"issue":"4","key":"8315_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1467-789X.2007.00411.x","volume":"9","author":"R Ross","year":"2008","unstructured":"Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev. 2008;9(4):312\u201325.","journal-title":"Obes Rev"},{"key":"8315_CR33","doi-asserted-by":"publisher","first-page":"j2099","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.","journal-title":"BMJ"},{"key":"8315_CR34","doi-asserted-by":"crossref","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"6","key":"8315_CR35","doi-asserted-by":"publisher","first-page":"e207247","DOI":"10.1001\/jamanetworkopen.2020.7247","volume":"3","author":"GL Daumit","year":"2020","unstructured":"Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AE, Cather C, et al. Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(6):e207247.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"8315_CR36","doi-asserted-by":"publisher","first-page":"e220202","DOI":"10.1001\/jamanetworkopen.2022.0202","volume":"5","author":"RC Rossom","year":"2022","unstructured":"Rossom RC, Crain AL, O\u2019Connor PJ, Waring SC, Hooker SA, Ohnsorg K, et al. Effect of Clinical Decision Support on Cardiovascular Risk Among Adults With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e220202.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"8315_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1094428114548590","volume":"17","author":"DA Newman","year":"2014","unstructured":"Newman DA. Missing data: Five practical guidelines. Organizational Res Methods. 2014;17(4):372\u2013411.","journal-title":"Organizational Res Methods"},{"issue":"10","key":"8315_CR38","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2337\/diabetes.51.10.3069","volume":"51","author":"SH Golden","year":"2002","unstructured":"Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes. 2002;51(10):3069\u201376.","journal-title":"Diabetes"},{"issue":"9438","key":"8315_CR39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"3","key":"8315_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339\u201347.","journal-title":"World Psychiatry"},{"key":"8315_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.","journal-title":"Implement Sci"},{"issue":"1","key":"8315_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1037\/0003-066X.55.1.68","volume":"55","author":"RM Ryan","year":"2000","unstructured":"Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55(1):68\u201378.","journal-title":"Am Psychol"},{"issue":"3","key":"8315_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1037\/a0012801","volume":"49","author":"EL Deci","year":"2008","unstructured":"Deci EL, Ryan RM. Self-determination theory: A macrotheory of human motivation, development, and health. Can Psychol. 2008;49(3):182.","journal-title":"Can Psychol"},{"key":"8315_CR44","unstructured":"Fogg BJ. Tiny habits: The small changes that change everything. Harvest; 2020."},{"key":"8315_CR45","doi-asserted-by":"crossref","unstructured":"Fogg BJ, editor. A behavior model for persuasive design. Proceedings of the 4th international Conference on Persuasive Technology; 2009.","DOI":"10.1145\/1541948.1541999"},{"issue":"1","key":"8315_CR46","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1186\/s12913-022-08992-2","volume":"22","author":"A Gremyr","year":"2022","unstructured":"Gremyr A, Holmberg C, Thor J, Malm U, G\u00e4re BA, Andersson AC. How a point-of-care dashboard facilitates co-production of health care and health for and with individuals with psychotic disorders: a mixed-methods case study. BMC Health Serv Res. 2022;22(1):1599.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08315-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:32:40Z","timestamp":1783344760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08315-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8315"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08315-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7972355\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial is conducted in accordance with the CIP, the ethical principles of the Declaration of Helsinki, the principles of SS-EN ISO 14155:2020, and all applicable national and international regulations. These measures ensure both participant safety and data quality. The trial did not commence until the required regulatory and ethical reviews were completed with non-negative outcomes, in compliance with the MDR and national legislation. Any additional requirements imposed by the Ethics Committee or regulatory authorities are implemented accordingly. The protocol (version 2.0), worksheets, PISs, informed consent forms, and all other trial materials were approved by the Swedish Medical Products Agency on November 6, 2024 (Dnr: 5.1-2024-92319) and the Swedish Ethical Review Authority on December 18, 2024 (Dnr: 2024-07362-01). The first substantial amendment to the protocol (version 3.0\/Amendment 1), replacing version 2.0, was approved by the Swedish Ethical Review Authority on June 25, 2025 (Dnr: 2025-04238-02) and by the Swedish Medical Products Agency on July 1, 2025 (Dnr: 5.1-2024-92319 [5.1.1-2025-050512]). Individual written informed consent to participate is obtained from all eligible patients prior to enrollment. All clinical investigation team members received training in Good Clinical Practice (GCP) and trial procedures before initiating data collection. The trial is registered at ClinicalTrials.gov (NCT06781801; date registered: 16 January 2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The trial is registered at ClinicalTrials.gov, and summary-level results will be submitted for publication in peer-reviewed scientific journals. The first results are expected to be available in 2027. Findings will also be shared at national and international conferences, through meetings with regional health authorities, and via various media channels. Trial participants are informed that they may obtain trial results through the site\u2019s PI once available. The trial also includes collaboration with the Schizophrenia Association in Gothenburg to facilitate communication of results to broader audiences. All abstracts and publications will adhere to the authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE). The full trial CIP is available at ClinicalTrials.gov (NCT06781801).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dissemination policy"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}